PHG

The Most Important Facts About Koninklijke Philips

Now trading at a price of $17.79, Koninklijke Philips has moved -4.3% Friday.

Koninklijke Philips shares moved -38.5% over the last 52 weeks, with a high of $31.06 and a low of $11.75. During this time, the stock lagged the S&P 500 index by -33.0%. As of January 2022, the company's 50-day average price is $17.09. Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The large-cap Health Care company has 77,233 full time employees and is based in Amsterdam, Netherlands. Koninklijke Philips has returned a 4.6% dividend yield over the last 12 months.

a Declining EPS Growth Trend with a Highly Leveraged Balance Sheet:

2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue (MM) $19,482 $19,535 $17,156 $17,827
Revenue Growth n/a 0.27% -12.18% 3.91%
Gross Margins 45.6% 45.0% 41.8% 40.4%
Gross Margins Growth n/a -1.32% -7.11% -3.35%
Operating Margins 8.4% 7.9% 3.2% -1.0%
Operating Margins Growth n/a -5.95% -59.49% -131.25%
Net Margins 6.0% 6.08% 19.35% -9.02%
Net Margins Growth n/a 1.33% 218.26% -146.61%
Earnings Per Share $1.25 $1.29 $3.65 -$1.92
EPS Growth n/a 3.2% 182.95% -152.6%
Diluted Shares (MM) 931 917 910 881
Free Cash Flow (MM) $1,018 $1,835 $866 -$979
FCF Growth n/a 80.26% -52.81% -213.05%
Capital Expenditures (MM) -$1,013 -$942 -$763 -$806
Net Debt / EBITDA 1.27 1.15 2.31 4.73

Koninklijke Philips has negative earnings for the current period, so its trailing twelve month P/E ratio is not meaningful. But based on its EPS guidance of 0.96, the company has a forward P/E ratio of 18.5. In contrast, the Health Care sector's average P/E ratio is 24.45.

On the other hand, Koninklijke Philips is possibly undervalued in terms of its net assets because its P/B ratio is 1.2 compared to its sector average of 4.16.

Most of the Market Indicators on Koninklijke Philips Are Negative:

2 analysts are following Koninklijke Philips and have set target prices ranging from $18.0 to $19.0 per share. On average, they have given the company a rating of hold. At the current price of $17.79, PHG is trading -3.84% away from its average analyst target price of $18.5 per share, implying an analyst consensus of some upside potential for the stock.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS